Clinuvel Pharmaceuticals Ltd (CLVLY)
10.00
+0.04
(+0.45%)
USD |
OTCM |
Sep 23, 16:00
Clinuvel Pharmaceuticals Market Cap: 500.78M for Sept. 23, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| September 23, 2024 | 500.78M |
| September 20, 2024 | 498.52M |
| September 19, 2024 | 498.52M |
| September 18, 2024 | 490.01M |
| September 17, 2024 | 506.79M |
| September 16, 2024 | 500.78M |
| September 13, 2024 | 500.78M |
| September 12, 2024 | 495.77M |
| September 11, 2024 | 493.27M |
| September 10, 2024 | 483.25M |
| September 09, 2024 | 488.26M |
| September 06, 2024 | 471.98M |
| September 05, 2024 | 471.98M |
| September 04, 2024 | 502.28M |
| September 03, 2024 | 502.28M |
| August 30, 2024 | 515.80M |
| August 29, 2024 | 517.30M |
| August 28, 2024 | 472.41M |
| August 27, 2024 | 462.72M |
| August 26, 2024 | 463.22M |
| August 23, 2024 | 463.22M |
| August 22, 2024 | 447.70M |
| August 21, 2024 | 453.70M |
| August 20, 2024 | 458.71M |
| August 19, 2024 | 444.19M |
| Date | Value |
|---|---|
| August 16, 2024 | 468.23M |
| August 15, 2024 | 460.72M |
| August 14, 2024 | 470.73M |
| August 13, 2024 | 464.22M |
| August 12, 2024 | 468.73M |
| August 09, 2024 | 458.71M |
| August 08, 2024 | 455.46M |
| August 07, 2024 | 450.70M |
| August 06, 2024 | 461.72M |
| August 05, 2024 | 421.66M |
| August 02, 2024 | 473.24M |
| August 01, 2024 | 485.75M |
| July 31, 2024 | 495.27M |
| July 30, 2024 | 501.78M |
| July 29, 2024 | 500.78M |
| July 26, 2024 | 500.78M |
| July 25, 2024 | 488.26M |
| July 24, 2024 | 488.26M |
| July 23, 2024 | 513.80M |
| July 22, 2024 | 513.80M |
| July 19, 2024 | 510.29M |
| July 18, 2024 | 513.30M |
| July 17, 2024 | 510.29M |
| July 16, 2024 | 518.31M |
| July 15, 2024 | 518.31M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
400.22M
Minimum
Mar 18 2020
1.546B
Maximum
Sep 23 2021
755.35M
Average
707.98M
Median
Market Cap Benchmarks
| Alterity Therapeutics Ltd | 10.80M |
| Kazia Therapeutics Ltd | 9.629M |
| Immutep Ltd | 332.65M |
| Opthea Ltd | 330.58M |
| Mesoblast Ltd | 817.52M |
Market Cap Related Metrics
| PE Ratio | 21.81 |
| PS Ratio | 8.822 |
| PEG Ratio | 0.3731 |
| Price to Book Value | 3.690 |
| Price | 10.00 |
| Earnings Yield | 4.58% |
| PEGY Ratio | 0.3709 |
| Operating PE Ratio | 16.19 |
| Normalized PE Ratio | 21.81 |